| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/24/2004 | CN1483444A Formula of rehmannia root effervescence preparation and process for preparing same |
| 03/24/2004 | CN1483433A Compound activated daemonorops draco |
| 03/24/2004 | CN1483432A Clathrate compound of daemonorops draco |
| 03/24/2004 | CN1483427A Medicine for treating pile |
| 03/24/2004 | CN1483418A Fat-reducing tea and preparation method trereof |
| 03/24/2004 | CN1483414A Animal cephalin capsule |
| 03/24/2004 | CN1142996C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 03/24/2004 | CN1142995C Use of lactobacillus for reduction of fibrinogen level in blood |
| 03/24/2004 | CN1142936C Condensed thienopyrimidines with phosphodiesterase-V inhibiting action, preparation process and use thereof |
| 03/24/2004 | CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use |
| 03/24/2004 | CN1142918C Carboxylic acid derivs, their preparation and their use |
| 03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |
| 03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 03/24/2004 | CN1142786C Medicine for treating coronary heart disease |
| 03/24/2004 | CN1142781C Use of 9-deoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'- interphenylene)-13,14-dihydro-prostaglandin F, to treat peripheral vascular disease |
| 03/24/2004 | CN1142753C Skin patches for providing testosterone |
| 03/23/2004 | US6710209 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/23/2004 | US6710184 Crystalline solids of carvedilol and processes for their preparation |
| 03/23/2004 | US6710183 Process for the synthesis of a known tetrazol derivative |
| 03/23/2004 | US6710171 Isolated dna encoding protein having specified amino acid sequence; treating or preventing arteriosclerosis and restenosis after treatment of artery occlusion |
| 03/23/2004 | US6710165 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 03/23/2004 | US6710088 Inorganic ion receptor-active compounds |
| 03/23/2004 | US6710080 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 03/23/2004 | US6710075 Compounds having a cyclopentabenzofuran core shown to exhibit potent cytotoxic and cytostatic effects on cancer cell growth and viability |
| 03/23/2004 | US6710070 Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use |
| 03/23/2004 | US6710069 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/23/2004 | US6710067 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/23/2004 | US6710063 Activators of PPAR delta |
| 03/23/2004 | US6710060 4-hydroxypiperidine derivatives having antiarrhythmic activity |
| 03/23/2004 | US6710057 Inhibitors of factor xa, as anticoagulants for prophylaxis and treatment of thromboembolic disorders |
| 03/23/2004 | US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii. |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710052 Anticancer agents |
| 03/23/2004 | US6710048 Selective inhibitors of vascular endothelial growth factor receptor tyrosine kinase; to treat solid-tumor cancers, angiogenesis, diabetic retinopathy, rheumatoid arthritis, endometriosis and psoriasis |
| 03/23/2004 | US6710042 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709651 Administering peptidase; substance p antagonist; central nervous system disorders |
| 03/23/2004 | CA2350074C Aerosols comprising nanoparticle drugs |
| 03/23/2004 | CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/19/2004 | CA2400254A1 Compositions and methods for treating heart disease |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022753A1 Novel actin-associated cytosekelton protein lacs |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022582A1 Peptidomimetic drugs |
| 03/18/2004 | WO2004022572A1 Compounds that interact with kinases |
| 03/18/2004 | WO2004022569A1 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 03/18/2004 | WO2004022553A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE |
| 03/18/2004 | WO2004022551A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | WO2004022544A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 03/18/2004 | WO2004022540A2 Pyridazinone and pyridone derivatives as adenosine antagonists |
| 03/18/2004 | WO2004022539A1 Naphthyl ether compounds and their use |
| 03/18/2004 | WO2004022533A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2004022128A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 03/18/2004 | WO2004022123A1 Coated stent |
| 03/18/2004 | WO2004022090A1 A method of modulating endothelial cell activity |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004022085A1 Zinc transporter compositions for the treatment of cardiovascular diseases |
| 03/18/2004 | WO2004022066A2 Method and means for the treatment of vascular and cardiac diseases |
| 03/18/2004 | WO2004022034A1 Dermatological preparation for the treatment of skin lesions |
| 03/18/2004 | WO2004022032A2 Pharmaceutical dosage form comprising a sulfite compound |
| 03/18/2004 | WO2004021973A2 Pravastatin pharmaceutical formulations and methods of their use |
| 03/18/2004 | WO2004009596A3 Pyrazolopyrimidines as kinase inhibitors |
| 03/18/2004 | WO2004000204A8 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/18/2004 | WO2003099192A3 Bis-aromatic alkanols |
| 03/18/2004 | WO2003097608A3 Opioid and opioid-like compounds and uses thereof |
| 03/18/2004 | WO2003095421A8 Amino acid analogues |
| 03/18/2004 | WO2003094830A3 Novel azacyclic ethynyl derivatives |
| 03/18/2004 | WO2003084936A3 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 03/18/2004 | WO2003076950A3 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 03/18/2004 | WO2003076461A3 Dimeric tf antagonist comprising two factor vii polypeptides |
| 03/18/2004 | WO2003075944A3 Interferon beta-like molecules for treatment of stroke |
| 03/18/2004 | WO2003072734A3 Bipolar trans carotenoid salts and their uses |
| 03/18/2004 | WO2003070965A3 The eaat2 promoter and uses thereof |
| 03/18/2004 | WO2003066595A3 2 - piperazine - pyridines useful for treating pain |
| 03/18/2004 | WO2003065984A3 Methods and compositions for treating cardiovascular disease |
| 03/18/2004 | WO2003044172B1 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 03/18/2004 | WO2003041725A3 Regulation of cgmp-specific phosphodiesterase 9a |
| 03/18/2004 | WO2003039434A3 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof |
| 03/18/2004 | WO2003033524A3 Peptidyl ketones as inhibitors of dpiv |
| 03/18/2004 | WO2003015704A3 Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders |
| 03/18/2004 | WO2003011222A3 Thrombin inhibitors |
| 03/18/2004 | WO2002095034A9 A retinoic acid metabolizing cytochrome p450 |
| 03/18/2004 | WO2002076435A3 Lipid profile modulation with steroids |
| 03/18/2004 | WO2002055694A3 Discriminative nucleic acid analysis using clone sequence signatures |
| 03/18/2004 | US20040054213 Ophthalmic compositions for treating ocular hypertension |
| 03/18/2004 | US20040054184 Preservative for organs, synthetic blood |
| 03/18/2004 | US20040054180 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 03/18/2004 | US20040054177 Novel benzimidazole derivatives |
| 03/18/2004 | US20040054172 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids |
| 03/18/2004 | US20040054155 Oligonucleotide compositions with enhanced efficiency |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040054143 Vegf peptides and their use for inhibiting angiogenesis |
| 03/18/2004 | US20040054135 Calcineurin polypeptide for diagnosis and treatment of cardiovascular disorders |
| 03/18/2004 | US20040054005 Sodium channel blocker compositions and the use thereof |
| 03/18/2004 | US20040054001 For preparing a pharmaceutical composition for treating diseases that may be influenced by NF-kappaB, particularly psoriasis |
| 03/18/2004 | US20040053998 For treating restenosis in tissue wherein smooth muscle cell migration occurs following angioplasty; for treatment of chronic inflammation, ischemic diseases and cancer |
| 03/18/2004 | US20040053993 Compositions of tocol-soluble therapeutics |